Laboratory Evaluation of Antithrombin, Protein C, and Protein S.
Journal
Seminars in thrombosis and hemostasis
ISSN: 1098-9064
Titre abrégé: Semin Thromb Hemost
Pays: United States
ID NLM: 0431155
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
23
10
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
Thrombophilia is a complex disease process, clinically manifesting in various forms of venous thromboembolism. Although both genetic and acquired (or environmental) risks factors have been reported, the presence of a genetic defect (antithrombin [AT], protein C [PC], protein S [PS]) is considered three of the major contributing factors of thrombophilia. The presence of each of these risk factors can be established by clinical laboratory analysis; however, the clinical provider and laboratory personnel must understand the testing limitations and shortcomings associated with the assays for these factors to be able to ensure an accurate diagnosis. This article will describe the major pre-analytical, analytical, and post-analytical issues associated with the various types of assays and discuss evidence-based algorithms for analyzing AT, PC, and PS in plasma.
Identifiants
pubmed: 36940716
doi: 10.1055/s-0043-1764468
doi:
Substances chimiques
Antithrombins
0
Protein C
0
Anticoagulants
0
Antithrombin III
9000-94-6
Protein S
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
641-650Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
None declared.